Karyopharm Therapeutics Inc (KPTI) poses a Brand-New Opportunity for Investors with beta value of 0.14
Karyopharm Therapeutics Inc (NASDAQ: KPTI) established initial surge of 25.45% at $1.38, before settling in for the price of $1.10 at the close. Taking a